Taysha Gene Therapies Inc Share Price Today: Live Updates & Key Insights
Taysha Gene Therapies Inc share price today is $4.53, up -3.51%. The stock opened at $4.6 against the previous close of $4.56, with an intraday high of $4.6 and low of $4.35.
Taysha Gene Therapies Inc Share Price Chart
Taysha Gene Therapies Inc
Taysha Gene Therapies Inc Share Price Performance
Taysha Gene Therapies Inc Institutional Holdings
Taysha Gene Therapies Inc Market Status
Taysha Gene Therapies Inc Fundamentals
Market Cap 1205.25 M
PB Ratio 5.7038
PE Ratio 0.0
Enterprise Value 1020.75 M
Total Assets 343.32 M
Volume 5529503
Taysha Gene Therapies Inc Company Financials
About Taysha Gene Therapies Inc & investment objective
Company Information Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of severe monogenic diseases of the central nervous system. The company primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; and TSHA-114 for the treatment of fragile X syndrome. The company has research, collaboration, and license agreement with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.
Organisation Biotechnology
Employees 99
Industry Biotechnology
CEO Mr. Sean P. Nolan
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Taysha Gene Therapies Inc FAQs
What is the share price of Taysha Gene Therapies Inc today?
The current share price of Taysha Gene Therapies Inc is $4.53.
Can I buy Taysha Gene Therapies Inc shares in India?
Yes, Indian investors can buy Taysha Gene Therapies Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Taysha Gene Therapies Inc shares in India?
You can easily invest in Taysha Gene Therapies Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Taysha Gene Therapies Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Taysha Gene Therapies Inc.
Can I buy fractional shares of Taysha Gene Therapies Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Taysha Gene Therapies Inc?
Taysha Gene Therapies Inc has a market cap of $1205.25 M.
In which sector does Taysha Gene Therapies Inc belong?
Taysha Gene Therapies Inc operates in the Biotechnology sector.
What documents are required to invest in Taysha Gene Therapies Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Taysha Gene Therapies Inc?
The PE ratio of Taysha Gene Therapies Inc is N/A and the PB ratio is 5.70.